4CAINE M, RAZ S,ZEIGLER M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck[J]. Br J Urol,1975,47(2) :193-202.
5NARAYAN P,EVANS C P,MOON T. Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia [ J ]. J Urol,2003,170 ( 2Pt1) :498-502.
6MCCONNELL J D, ROEHRBOM C G, BAUTISTA O M,et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia [ J ]. N Engl J Med, 2003,349 ( 25 ) : 2387 -2398.
7DJAVAN B,CHAPPLE C,MILANI S,et al. State of the art on the efficacy and tolerability of alphal-adrenoceptor antagonists in patients with lower urinary tract symptom suggestive of benign prostatic hyperplasia [ J ]. Urology, 2004, 64(6) :1081-1088.
8ROEHRBORN C G, BOYLE P, BERGNER D,et al. Serum prostate-specific antigen and prostate volume predict lone- term changes in symptoms and flow rate:results of a four years,randomised trial comparing finasteride versus placebo [ J ]. Urology, 1999,54 ( 4 ) :662-669.
9NICKEL J C, FRADET Y, BOAKE R C,et al. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia:results of a 2-year randomised controlled trial (the PROSPECT Study) [ J ]. Can Med Assoc J, 1996,155 (9) :1251-1259.
10THOMPSON I M, GOODMAN P J, TANGEN C M,et al. The influence of finasteride on the development of prostate cancer [ J ]. New Engl J Med, 2003,349 ( 3 ) : 215 -224.
